Division of Bioresources and Bioenvironmental Sciences, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka, 812-8581, Japan.
Cytotechnology. 2000 Nov;34(3):213-23. doi: 10.1023/A:1008183400709.
Hydrocortisone was investigated for its ability todifferentiate human leukemia KU812 cells into maturehematopoietic cells including basophils. Hydrocortisonetreatment increased the amount of intracellular histamine byup-regulation of L-histidine decarboxylase (HDC) mRNA andenhanced cell surface expression of the high affinity IgEreceptor FcepsilonRI. Histamine is catalyzed from L-histidine byHDC, which in blood cell types is only expressed in basophilsand mast cells. Cells, on which the FcepsilonRI expression wasenhanced by hydrocortisone, were shown to release histaminewhen stimulated with anti-IgE antibody after sensitizationwith myeloma IgE, implying that the induced FcepsilonRI moleculeswere able to transduce a signal for degranulation. Theseresults suggest that hydrocortisone promotes differentiationof KU812 cells into functionally mature basophilic cells.
研究了氢化可的松将人白血病 KU812 细胞分化为包括嗜碱性粒细胞在内的成熟造血细胞的能力。氢化可的松治疗通过上调 L-组氨酸脱羧酶 (HDC) mRNA 增加细胞内组氨酸的含量,并增强高亲和力 IgE 受体 FcepsilonRI 的细胞表面表达。组氨酸由 HDC 从 L-组氨酸催化,在血细胞类型中仅在嗜碱性粒细胞和肥大细胞中表达。用骨髓瘤 IgE 致敏后,用抗 IgE 抗体刺激后,FcepsilonRI 表达增强的细胞释放组氨酸,这表明诱导的 FcepsilonRI 分子能够传递脱颗粒信号。这些结果表明,氢化可的松促进了 KU812 细胞向功能成熟的嗜碱性细胞的分化。